Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival For more than 50 years, heparin and vitamin K antagonists (VKAs) have been the anticoagulant drugs used to prevent ...

Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...

The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the use of anticoagulant and antiplatelet therapy in patients with atrial fibrillation (AF) or ...

Physicians should aim to use the least amount of antithrombotic therapy as possible in their patients undergoing TAVI, according to a new European consensus statement. In general, over the long term, ...

The final report from the HORIZONS-AMI trial in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction shows that the early benefits of ...

Over the last year, an abundance of clinical research has been undertaken to understand common pathologies of COVID-19 illness, including the high rates of thrombosis and endothelial injury. A new ...

With the advent of antiplatelet drugs such as clopidogrel and dipyridamole, and trial results indicating the superiority of combined drug regimens for preventing thrombosis, antithrombotic treatment ...

For decades hemophilia and allied bleeding disorders caused by inherited deficiency of clotting factors have been considered conditions protecting against thromboembolism (TE). This opinion was coined ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — The past year has seen much new research about antithrombotic therapy for primary prevention, secondary ...

Patients with decreased kidney function should have a detailed discussion with their doctor about the possible risks and benefits of proceeding with antithrombotic therapy. Reduced kidney function ...

Because of rapidly changing guidelines in response to multiple clinical trials of new therapies, the management of antithrombotic agents for patients after an acute coronary syndrome is becoming ...

Data are presented as number (percentage) of patients unless otherwise indicated. Number provided after the semicolon indicates the total number of patients for that variable. The EORP-AF General Long ...